Aliases & Classifications for Autoimmune Disease

MalaCards integrated aliases for Autoimmune Disease:

Name: Autoimmune Disease 58 12 30 17
Autoimmune Diseases 56 44 74
Autoimmune Hypersensitivity Disease 12 15
Hypersensitivity Reaction Type Ii Disease 12
Type Ii Hypersensitivity Reaction Disease 17
Autoimmune Disorder 15

Characteristics:

OMIM:

58
Inheritance:
autosomal dominant gene epistatic to other secondary genes conferring specificity to the autoimmune phenotype


HPO:

33
autoimmune disease:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:417
OMIM 58 109100
ICD9CM 36 720
MedGen 43 C0004364
SNOMED-CT via HPO 70 263681008

Summaries for Autoimmune Disease

MedlinePlus : 44 Your body's immune system protects you from disease and infection. But if you have an autoimmune disease, your immune system attacks healthy cells in your body by mistake. Autoimmune diseases can affect many parts of the body. No one is sure what causes autoimmune diseases. They do tend to run in families. Women - particularly African-American, Hispanic-American, and Native-American women - have a higher risk for some autoimmune diseases. There are more than 80 types of autoimmune diseases, and some have similar symptoms. This makes it hard for your health care provider to know if you really have one of these diseases, and if so, which one. Getting a diagnosis can be frustrating and stressful. Often, the first symptoms are fatigue, muscle aches and a low fever. The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain and swelling. The diseases may also have flare-ups, when they get worse, and remissions, when symptoms get better or disappear. Treatment depends on the disease, but in most cases one important goal is to reduce inflammation. Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response.

MalaCards based summary : Autoimmune Disease, also known as autoimmune diseases, is related to vitiligo-associated multiple autoimmune disease susceptibility 1 and autoimmune disease of endocrine system. An important gene associated with Autoimmune Disease is GAS5 (Growth Arrest Specific 5), and among its related pathways/superpathways are Allograft rejection and Th17 cell differentiation. The drugs Sofosbuvir and Ledipasvir have been mentioned in the context of this disorder. Affiliated tissues include t cells, testes and bone, and related phenotypes are autoimmune antibody positivity and hematopoietic system

Disease Ontology : 12 An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.

Wikipedia : 77 An autoimmune disease is a condition arising from an abnormal immune response to a normal body part.... more...

Description from OMIM: 109100

Related Diseases for Autoimmune Disease

Diseases related to Autoimmune Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 812)
# Related Disease Score Top Affiliating Genes
1 vitiligo-associated multiple autoimmune disease susceptibility 1 34.8 AIRE CTLA4 NLRP1 PTPN22
2 autoimmune disease of endocrine system 34.1 AIRE CTLA4 IFNG PTPN22
3 autoimmune disease of eyes, ear, nose and throat 34.0 IL10 IL17A TNF
4 autoimmune disease of musculoskeletal system 34.0 APOH IL10 IL17A PTPN22 TNF TNFSF13B
5 autoimmune disease of central nervous system 34.0 IFNG IL10 IL17A MBP TNF
6 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 33.6 AIRE CTLA4 IFNG IL10 IL17A PTPN22
7 hashimoto thyroiditis 33.1 AIRE CTLA4 IFNG PTPN22
8 lupus erythematosus 33.1 APOH CTLA4 IL10 NLRP1 PTPN22 TNF
9 rheumatoid arthritis 32.9 CTLA4 IFNG IL10 IL17A NLRP1 PTPN22
10 neuromyelitis optica 32.9 IL17A MBP TNFSF13B
11 multiple sclerosis 32.9 CTLA4 IFNG IL10 IL17A MBP TNF
12 systemic lupus erythematosus 32.9 APOH CTLA4 IFNG IL10 IL17A NLRP1
13 mixed connective tissue disease 32.9 APOH IFNG IL10 TNF
14 alopecia areata 32.8 AIRE CTLA4 IFNG PTPN22 TNF
15 myasthenia gravis 32.7 AIRE CTLA4 IFNG IL10 MBP TNF
16 autoimmune pancreatitis 32.7 CTLA4 ENO1 IL10 TNFSF13B
17 diabetes mellitus, insulin-dependent 32.6 AIRE CTLA4 IFNG IL10 PTPN22
18 autoimmune uveitis 32.6 IFNG IL10 IL17A TNF
19 vogt-koyanagi-harada disease 32.6 IL10 IL17A NLRP1 PTPN22
20 behcet syndrome 32.5 APOH CTLA4 ENO1 IFNG IL10 IL17A
21 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 32.5 AIRE IFNG IL10
22 autoimmune myocarditis 32.5 IFNG TNF
23 autoimmune addison disease 32.2 AIRE CTLA4 NLRP1
24 punctate inner choroidopathy 32.1 IL10 TNF
25 reactive arthritis 32.1 IFNG IL10 IL17A TNF
26 melioidosis 32.1 IFNG IL10 TNF
27 autoimmune retinopathy 32.1 AIRE ENO1
28 interstitial lung disease 32.1 IFNG IL10 TNF
29 autoimmune optic neuritis 32.1 IL10 IL17A MBP
30 autoimmune atherosclerosis 32.0 APOH IL10
31 immune system disease 32.0 APOH IFNG IL10 IL17A MBP TNF
32 arthritis 31.8 IFNG IL10 IL17A NLRP1 PTPN22 TNF
33 hematopoietic stem cell transplantation 31.7 CTLA4 IFNG IL10 TNF
34 vasculitis 31.4 APOH TNF TNFSF13B
35 uveitis 31.1 CTLA4 IFNG IL10 IL17A TNF
36 colitis 31.1 CTLA4 IFNG IL10 IL17A TNF
37 connective tissue disease 31.0 APOH IFNG IL10 TNF TNFSF13B
38 ulcerative colitis 30.9 IFNG IL10 IL17A TNF
39 common variable immunodeficiency 30.9 CTLA4 IFNG IL10 TNF TNFSF13B
40 dermatitis, atopic 30.8 IFNG IL10 IL17A TNF
41 graft-versus-host disease 30.8 IFNG IL10 TNF
42 neuritis 30.8 IFNG MBP TNF
43 chronic graft versus host disease 30.8 IFNG IL10 TNF TNFSF13B
44 rheumatic disease 30.7 APOH IFNG IL10 TNF
45 candidiasis 30.7 AIRE IFNG IL10 IL17A
46 bacterial infectious disease 30.6 IFNG IL10 IL17A TNF
47 inflammatory bowel disease 30.6 GAS5 IFNG IL10 IL17A STAT3 TNF
48 malaria 30.6 CTLA4 IFNG IL10 IL17A TNF
49 hypoadrenocorticism, familial 30.5 AIRE CTLA4 PTPN22
50 periodontitis 30.5 IFNG IL10 IL17A TNF

Graphical network of the top 20 diseases related to Autoimmune Disease:



Diseases related to Autoimmune Disease

Symptoms & Phenotypes for Autoimmune Disease

Human phenotypes related to Autoimmune Disease:

33
# Description HPO Frequency HPO Source Accession
1 autoimmune antibody positivity 33 HP:0030057

Symptoms via clinical synopsis from OMIM:

58
Immunology:
autoimmune disease

Lab:
high titer autoantibody

Clinical features from OMIM:

109100

MGI Mouse Phenotypes related to Autoimmune Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.13 AIRE CTLA4 IFNG IL10 IL17A ITCH
2 homeostasis/metabolism MP:0005376 10.03 AIRE APOH CTLA4 IFNG IL10 IL17A
3 digestive/alimentary MP:0005381 9.97 AIRE CTLA4 IFNG IL10 IL17A PTPN22
4 immune system MP:0005387 9.97 AIRE CTLA4 IFNG IL10 IL17A ITCH
5 liver/biliary system MP:0005370 9.5 AIRE CTLA4 IFNG IL10 PTPN22 STAT3
6 respiratory system MP:0005388 9.28 AIRE CTLA4 IFNG IL10 IL17A ITCH

Drugs & Therapeutics for Autoimmune Disease

Drugs for Autoimmune Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1256)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
2
Ledipasvir Approved Phase 4 1256388-51-8 67505836
3
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 79902-63-9 54454
4
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
5
Azithromycin Approved Phase 4,Phase 2,Phase 1 83905-01-5 447043 55185
6
Selenium Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 7782-49-2
7
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-66-6 32051
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
9
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1401-55-4
10
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24280-93-1 446541
11
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
12
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
14
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
15
Insulin Aspart Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 116094-23-6 16132418
16
Insulin Lispro Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 133107-64-9
17
Insulin glulisine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 207748-29-6
18
Enalapril Approved, Vet_approved Phase 4,Phase 2,Not Applicable 75847-73-3 40466924 5362032
19
Enalaprilat Approved Phase 4,Phase 2,Not Applicable 76420-72-9 6917719
20
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
21
Saxagliptin Approved Phase 4,Phase 3,Phase 2 361442-04-8 11243969
22
Pancrelipase Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53608-75-6
23
Glucagon Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 16941-32-5
24
Losartan Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 114798-26-4 3961
25
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198
26
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
27
gastric inhibitory polypeptide Approved, Investigational Phase 4,Not Applicable 100040-31-1
28
Insulin Detemir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 169148-63-4 5311023
29
Insulin glargine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 160337-95-1
30
Glyburide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10238-21-8 3488
31
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-23-7 5754
32
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-03-3
33
Natalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 189261-10-7
34
4-Aminopyridine Approved Phase 4,Phase 3,Phase 2,Not Applicable 504-24-5 1727
35
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 65271-80-9 4212
36
Interferon beta-1b Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 145155-23-3
37
Exenatide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 141758-74-9 15991534
38
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
39
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
40
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 332348-12-6 10237
41
Sulfasalazine Approved Phase 4,Phase 3,Phase 2,Not Applicable 599-79-1 5359476 5353980
42
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 118-42-3 3652
43
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 185243-69-0
44
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 75706-12-6 3899
45
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 170277-31-3
46
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 428863-50-7
47
Diazoxide Approved Phase 4 364-98-7 3019
48
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2 202409-33-4 123619
49
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 15307-86-5 3033
50
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702

Interventional clinical trials:

(show top 50) (show all 9196)
# Name Status NCT ID Phase Drugs
1 Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease Unknown status NCT02691728 Phase 4 LDV/SOF FDC
2 Calcitriol in the Treatment of Immunoglobulin A Nephropathy Unknown status NCT00862693 Phase 4 Calcitriol
3 Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level Unknown status NCT00866229 Phase 4 Rosuvastatin;Simvastatin
4 Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease Unknown status NCT00188188 Phase 4 quinipril
5 An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Unknown status NCT02199925 Phase 4 Gammaplex 5%
6 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
7 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
8 Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial Unknown status NCT01679561 Phase 4 intralipid
9 Probiotics in Newly Recognized Type 1 Diabetes Unknown status NCT03032354 Phase 4 Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12
10 Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease Unknown status NCT01753401 Phase 4 Acthar;Placebo for Acthar
11 Selenium Supplementation in Youths With Autoimmune Thyroiditis Unknown status NCT02644707 Phase 4
12 Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses Unknown status NCT03021317 Phase 4 ACTHar
13 Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) Unknown status NCT03057470 Phase 4 50% bolus insulin correction;100% bolus insulin correction;150% bolus insulin correction
14 Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Unknown status NCT02981212 Phase 4 Mycophenolate Mofetil;ACE inhibitor;Corticosteroid;ARB
15 Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps. Unknown status NCT02685449 Phase 4 Insulin glulisine;Insulin aspart;Insulin lispro
16 Rituximab in Recurrent IgA Nephropathy Unknown status NCT02571842 Phase 4 Intravenous Rituximab;ACEI/ARB and corticosteroids
17 The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes Unknown status NCT02307695 Phase 4 Saxagliptin;Insulin
18 Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes Unknown status NCT02232971 Phase 4 Glucagon
19 Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy Unknown status NCT02231125 Phase 4 Losartan;Abelmoschus manihot
20 Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease Unknown status NCT01893996 Phase 4 Adalimumab;Placebo
21 Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study Unknown status NCT01800734 Phase 4
22 Comparing Long-acting Insulins During Exercise in Type 1 Diabetes Unknown status NCT01440439 Phase 4 Insulin glargine;Insulin detemir
23 Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes Unknown status NCT01280682 Phase 4 rituximab
24 Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis Unknown status NCT01271517 Phase 4 NPH insulin;Glargine;Detemir
25 A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy Unknown status NCT01184599 Phase 4 aliskiren
26 Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus Unknown status NCT01016457 Phase 4
27 A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria Unknown status NCT00843388 Phase 4 Spironolacton (hexalacton(R));placebo tablet
28 Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia? Unknown status NCT00472875 Phase 4 Glibenclamide
29 Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose Unknown status NCT00145353 Phase 4 Insulin NovoRapid versus Actrapid
30 Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis Unknown status NCT03046251 Phase 4 Natalizumab
31 Methylprednisolone During the Switch Between Natalizumab and Fingolimod Unknown status NCT02769689 Phase 4 Methylprednisolone;Placebo;natalizumab (NTZ);fingolimob (FTY)
32 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
33 Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya Unknown status NCT02325440 Phase 4 Fingolimod;Natalizumab
34 Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS Unknown status NCT02259361 Phase 4 Sustained-release oral dalfampridine;Placebo
35 Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients Unknown status NCT02809079 Phase 4 Mycophenolate mofetil;Prednisone
36 Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis Unknown status NCT01705457 Phase 4 Dietary Supplement: vitamin A;placebo
37 Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Unknown status NCT02021825 Phase 4 Mitoxantrone
38 Impact of Vitamin A on Multiple Sclerosis (MS) Unknown status NCT01417273 Phase 4 Drug: placebo
39 Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient Unknown status NCT01407211 Phase 4
40 Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) Unknown status NCT01339676 Phase 4 Colecalciferol;Placebo capsules
41 Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) Unknown status NCT00910598 Phase 4 glatiramer acetate
42 Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI Unknown status NCT00176592 Phase 4 Betaseron;Copaxone
43 IVIg for Demyelination in Diabetes Mellitus Unknown status NCT02372149 Phase 4 10% intravenous immunoglobulin (IVIg);0.9% sodium chloride
44 Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis Unknown status NCT01400464 Phase 4 Prednisone therapy and pharmacokinetic
45 Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel Unknown status NCT03082573 Phase 4 H.P. Acthar gel
46 An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes Unknown status NCT02962492 Phase 4 Exenatide/Exenatide extended release;Dapagliflozin;Placebo
47 Kunxian for the Treatment of Rheumatoid Arthritis Unknown status NCT02764515 Phase 4 Kunxian Capsule;Methotrexate
48 Inhibition of Co-Stimulation in Rheumatoid Arthritis Unknown status NCT02652273 Phase 4 Abatacept
49 Very Early Versus Delayed Etanercept in Patients With RA Unknown status NCT02433184 Phase 4 Etanercept;Methotrexate;Sulfasalazine;Hydroxychloroquine;Etanercept;Methotrexate
50 Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT02275299 Phase 4 Iguratimod;Leflunomide;Methotrexate

Search NIH Clinical Center for Autoimmune Disease

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Genetic Tests for Autoimmune Disease

Genetic tests related to Autoimmune Disease:

# Genetic test Affiliating Genes
1 Autoimmune Disease 30

Anatomical Context for Autoimmune Disease

MalaCards organs/tissues related to Autoimmune Disease:

42
T Cells, Testes, Bone, Thyroid, B Cells, Eye, Pancreas

Publications for Autoimmune Disease

Articles related to Autoimmune Disease:

(show top 50) (show all 6059)
# Title Authors Year
1
B Cell Dysfunction Associated With Aging and Autoimmune Diseases. ( 30873171 )
2019
2
Type I Interferons in Autoimmune Disease. ( 30332560 )
2019
3
Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer. ( 30616690 )
2019
4
The microbiome in systemic autoimmune disease: mechanistic insights from recent studies. ( 30624285 )
2019
5
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease. ( 30626016 )
2019
6
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). ( 30663016 )
2019
7
Galactomannan testing in the treatment of autoimmune disease combined with invasive fungal disease. ( 30663298 )
2019
8
Frequency of Positive ANCA Test in a Population With Clinical Symptoms Suggestive of Autoimmune Disease and the Interference of ANA in its Interpretation. ( 30704921 )
2019
9
Autoimmune Disease-Associated Hypertension. ( 30712132 )
2019
10
Publisher Correction: Approaches and advances in the genetic causes of autoimmune disease and their implications. ( 30728494 )
2019
11
The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE. ( 30728673 )
2019
12
Low HDL Cholesterol and High Risk of Autoimmune Disease: Two Population-Based Cohort Studies Including 117341 Individuals. ( 30745290 )
2019
13
Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease. ( 30759880 )
2019
14
The latitude-dependent autoimmune disease risk genes ZMIZ1 and IRF8 regulate mononuclear phagocytic cell differentiation in response to vitamin D. ( 30285234 )
2019
15
Estimating autoantibody signatures to detect autoimmune disease patient subsets. ( 29140482 )
2019
16
Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. ( 31110493 )
2019
17
Chimeric antigen receptor-engineered regulatory T lymphocytes: promise for immunotherapy of autoimmune disease. ( 31105041 )
2019
18
Regulatory T cells: the future of autoimmune disease treatment. ( 31104510 )
2019
19
Multisystem autoimmune disease caused by increased STAT3 phosphorylation, and dysregulated gene expression. ( 31073074 )
2019
20
Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. ( 31072742 )
2019
21
Clinical Manifestations and Mechanisms of Autoimmune Disease-Related Multiple Cerebral Infarcts. ( 31062611 )
2019
22
Complement Therapeutics in Autoimmune Disease. ( 31001274 )
2019
23
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models. ( 30988116 )
2019
24
Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease. ( 30986549 )
2019
25
CD28 null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection. ( 30984377 )
2019
26
DPP-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study. ( 30964554 )
2019
27
Depletion of PD-1-positive cells ameliorates autoimmune disease. ( 30952980 )
2019
28
Regulation of Inflammation in Autoimmune Disease. ( 30944837 )
2019
29
How does blood coagulation/neutrophils shape innate immunity and uncontrolled inflammation to autoimmune disease? ( 30943817 )
2019
30
Risk of congenital anomalies in infants born to women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. ( 30943142 )
2019
31
Myeloid disorders after autoimmune disease. ( 30927978 )
2019
32
Acute syphilitic posterior placoid chorioretinopathy: An infectious or autoimmune disease? ( 30923777 )
2019
33
Familial aggregation of myocardial infarction and coaggregation of myocardial infarction and autoimmune disease: a nationwide population-based cross-sectional study in Taiwan. ( 30898803 )
2019
34
Bacterial cell wall offcasts linked to autoimmune disease. ( 30894698 )
2019
35
DIAGNOSIS OF ENDOCRINE DISEASE: IgG4-related thyroid autoimmune disease. ( 30889549 )
2019
36
The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study. ( 30885252 )
2019
37
Non-Antibody-Secreting Functions of B Cells and Their Contribution to Autoimmune Disease. ( 30883216 )
2019
38
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer. ( 30877325 )
2019
39
Lacrimal Gland Orbital Lobe Cysts Associated With Lymphoid Hyperplasia or Mucosa-Associated Lymphoid Tissue Lymphoma in Patients With Chronic Autoimmune Disease. ( 30865072 )
2019
40
Pregnancy Immunogenetics and Genomics: Implications for Pregnancy-Related Complications and Autoimmune Disease. ( 30848957 )
2019
41
Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association. ( 30845238 )
2019
42
Uterine Artery Embolization in Patients With Autoimmune Disease: A Matched Case-Control Study. ( 30835520 )
2019
43
Feature Article: Altered morpho-functional features of bones in autoimmune disease-prone BXSB/MpJ- Yaa mice. ( 30818998 )
2019
44
Induced expression of Toll-like receptor 9 in peritubular capillary endothelium correlates with the progression of tubulointerstitial lesions in autoimmune disease-prone mice. ( 30813872 )
2019
45
Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease. ( 30805797 )
2019
46
Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy. ( 30787930 )
2019
47
Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study. ( 30779234 )
2019
48
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease. ( 30761150 )
2019
49
Pathogen infection and autoimmune disease. ( 30569518 )
2019
50
Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells. ( 30498131 )
2019

Variations for Autoimmune Disease

Copy number variations for Autoimmune Disease from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 21625 1 159859611 159867782 Copy number FCGR3B Autoimmune disease
2 21792 1 161592989 161601158 Copy number FCGR3B Autoimmune disease
3 21796 1 161592989 161601158 Deletion FCGR3B Autoimmune disease
4 208909 6 211050653 211252076 Copy number CYP21B Autoimmune disease
5 210508 6 30400000 36600000 Copy number CYP21A Autoimmune disease
6 210509 6 30400000 36600000 Copy number TNXA Autoimmune disease
7 211044 6 3197570 32111174 Copy number C4A Autoimmune disease
8 211046 6 3197570 32111174 Copy number C4B Autoimmune disease

Expression for Autoimmune Disease

Search GEO for disease gene expression data for Autoimmune Disease.

Pathways for Autoimmune Disease

Pathways related to Autoimmune Disease according to GeneCards Suite gene sharing:

(show all 26)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.77 CTLA4 IFNG IL10 IL17A TNF TNFSF13B
2
Show member pathways
12.48 IFNG IL10 IL17A STAT3 TNF
3
Show member pathways
12.47 IFNG IL10 IL17A STAT3 TNF
4
Show member pathways
12.34 CTLA4 IFNG IL10 IL17A TNF
5
Show member pathways
12.24 IFNG IL17A STAT3 TNF
6
Show member pathways
12.17 IFNG IL10 STAT3 TNF
7
Show member pathways
11.98 IFNG IL10 IL17A STAT3 TNFSF13B
8 11.86 IFNG MBP TNF TNFSF13B
9 11.84 CTLA4 IFNG IL10 IL17A ITCH NLRP1
10 11.81 IL10 IL17A STAT3 TNF
11 11.8 ENO1 IFNG STAT3
12 11.78 IFNG IL10 TNF
13
Show member pathways
11.67 IFNG IL10 IL17A STAT3 TNF
14 11.66 IFNG IL10 TNF
15 11.57 IFNG IL10 IL17A TNF
16 11.54 IFNG STAT3 TNF
17
Show member pathways
11.5 CTLA4 IFNG ITCH TNF
18 11.45 IL10 STAT3 TNF
19 11.44 IFNG IL10 TNF
20 11.41 IFNG IL10 IL17A TNF
21 11.31 CTLA4 IFNG IL17A TNF TNFSF13B
22 11.27 IFNG IL10 TNF
23 11.23 IL10 STAT3 TNF
24 11.18 IFNG IL17A TNF
25 11.12 IL10 IL17A TNF TNFSF13B
26 11.07 IFNG IL10 TNF

GO Terms for Autoimmune Disease

Cellular components related to Autoimmune Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 APOH ENO1 IFNG IL10 IL17A SIAE

Biological processes related to Autoimmune Disease according to GeneCards Suite gene sharing:

(show all 23)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.89 IFNG IL10 IL17A TNF TNFSF13B
2 cytokine-mediated signaling pathway GO:0019221 9.88 IL10 IL17A STAT3 TNF
3 negative regulation of gene expression GO:0010629 9.85 IFNG PTPN22 TNF ZFAT-AS1
4 response to organic substance GO:0010033 9.73 IL10 STAT3 TNF
5 humoral immune response GO:0006959 9.63 AIRE IFNG TNF
6 negative regulation of B cell proliferation GO:0030889 9.61 CTLA4 IL10
7 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.6 IFNG TNF
8 regulation of regulatory T cell differentiation GO:0045589 9.59 CTLA4 IFNG
9 negative regulation of growth of symbiont in host GO:0044130 9.58 IL10 TNF
10 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.57 IL10 TNF
11 positive regulation of ATP biosynthetic process GO:2001171 9.54 ENO1 STAT3
12 negative regulation of heterotypic cell-cell adhesion GO:0034115 9.52 IL10 MBP
13 positive regulation of metalloendopeptidase activity GO:1904685 9.51 MBP STAT3
14 endothelial cell apoptotic process GO:0072577 9.48 IL10 TNF
15 negative regulation of cytokine secretion involved in immune response GO:0002740 9.43 IL10 TNF
16 inflammatory response GO:0006954 9.43 IL10 IL17A ITCH NLRP1 STAT3 TNF
17 positive regulation of interleukin-23 production GO:0032747 9.4 IFNG IL17A
18 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.37 IFNG TNF
19 positive regulation of osteoclast differentiation GO:0045672 9.33 IFNG IL17A TNF
20 receptor biosynthetic process GO:0032800 9.32 IL10 TNF
21 positive regulation of vitamin D biosynthetic process GO:0060557 9.26 IFNG TNF
22 immune response GO:0006955 9.23 AIRE CTLA4 IFNG IL10 IL17A MBP
23 immune system process GO:0002376 10.01 CTLA4 ITCH NLRP1 PTPN22 TNFSF13B

Molecular functions related to Autoimmune Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 IFNG IL10 IL17A TNF TNFSF13B

Sources for Autoimmune Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN